Switching from natalizumab to ocrelizumab in patients with multiple sclerosis.
Seth N LevinChimere EzumaLibby LevineWendy S VargasRebecca S FarberPhilip Lawrence De JagerClaire S RileyPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
Keyphrases